[1] Watson MA,Fleming TP.Mammaglobin,a mammary specific member of the uteroglobin gene family is overexpressed in human breast cancer[J].Cancer Res,1996,56(4):860-865. [2] Becker RM,Darrow C,Zimonjie DB,et al.Identification of mammaglobin B,a novel member of the uteroglobin gene family[J].Genomies,1998,54(1):70-78. [3] Li C, Zhang T.Human mammaglobin:A specific marker for breast cancer prognosis[J].J BUON,2016,21(1):35-41. [4] 陈月凤,杨华伟,莫钦国,等.CK19和hMAM及SBEM检测乳腺癌微转移价值分析[J].中华肿瘤防治杂志,2014(3):198-202. [5] Bozhenko VK,Kharchenko NV,Vaskevich EF,et al.Mammaglobin in peripheral blood and tumor in breast cancer patients[J].Biomed Khim,2016,62(4):453-457. [6] Bölke E,Orth K,Gerber PA,et al.Gene expression of circulating tumour cells in breast cancer patients[J].Eur J Med Res,2009,14(10):426-432. [7] 鲍慧铮,陈力,李思莹,等.CKl9联合hMAM检测乳腺癌循环肿瘤细胞的临床价值[J].肿瘤,2014(2):153-157. [8] Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) method[J].Methods,2001,25(4):402-408. [9] 杨超,康炜,李建华,等.血清乳腺珠蛋白与乳腺癌的相关性及临床意义探讨[J]. 检验医学,2014,29(1):61-64. [10] 印滇,王亚非,杨莉,等.hMAM水平与乳腺癌早期诊断和癌微转移的相关性及临床意义研究[J].临床和实验医学杂志,2015,14(18):1512-1515. [11] GoedegebuurePS,Watson MA,Carsten T,et al.Mammaglobin-based strategies for treatment of breast cancer[J].Curr Cancer Drug Targets,2017,4(6):531-542. [12] Al Joudi FS.Human mammaglobin in breast cancer:a brief review of its clinical utility[J].Indian J Med Res,2014,139(5):675-685. [13] Marchetti A,Buttitta F,Bertacca G,et al.mRNA markers of breast cancer nodal metastases:comparision between mammaglobin and carcinoembryonic antigen in 248 patients[J].J Pathol,2001,195(2):186-190. [14] Chen Y,Zou TN,Wu ZP,et al.Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer[J].Int J Biol Markers,2010,25(2):59-68. [15] Koh EH,Cho YW,Mun YJ,et al.Upregulation of human mammaglobin reduces migration and invasion of breast cancer cells[J].Cancer Invest,2014,32(1):22-29. [16] Candido S,Abrams SL,Steelman LS,et al.Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy[J].Biochim Biophys Acta,2016,1863(3):438-448. [17] 张弘,姜义,关文曾,等.乳腺癌组织中基质金属蛋白酶2、9活性的测定[J].吉林大学学报:医学版,2002,28(6):591-599. [18] 孙亚楠,毛晓韵,刘晓虹,等.基底细胞样乳腺癌患者乳腺癌和癌旁正常乳腺组织中MTDH与MMP-9蛋白表达的相关性[J].吉林大学学报:医学版,2016,42(3):530-534,639. [19] Browne BC,O'Brien N,Duffy MJ,et al.HER-2 signaling and inhibition in breast cancer[J].Curr Cancer Drug Targets,2009,9(3):419-438. [20] 吴娜萍,肇毅,王珏,等.联合多标志物检测乳腺癌外周血循环肿瘤细胞与分子分型的相关性及临床意义[J].中华实验外科杂志,2014,(5):935-937. [21] 颜蕴文,张敬杰,徐晓军,等.联合检测乳腺癌患者外周血中细胞角蛋白19及人乳腺球蛋白mRNA的意义[J].中华乳腺病杂志:电子版,2010(2):45. [22] 葛明广.荧光定量PCR法检测人乳腺珠蛋白与乳腺癌微小转移诊断的研究[J].中外医疗,2008(28):25-27. [23] Roncella S,Ferro P,Bacigalupo B,et al.Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood[J].J Exp Clin Cancer Res,2005,24(2):265-271. [24] Lin YC,Wu Chou YH,Liao IC,et al.The expression of mammaglobin mRNA in peripheral blood of metastatic breast cancer patients as an adjunct to serum tumor markers[J].Cancer Lett,2003,191(1):93-99. [25] Liu Y,Ma L,Liu X,et al.Expression of human mammaglobin as a marker of bone marrow micrometastasis in breast cancer[J].Exp Ther Med,2012,3(3):550-554. [26] Lee GW,Kim JY,Koh EH,et al.Plasma human mammaglobin mRNA associated with poor outcome in patients with breast cancer[J].Genet Mol Res,2012,11(4):4034-4042. |